z-logo
open-access-imgOpen Access
COVID 19: AN OVERVIEW OF PATHOGENESIS, CYTOKINE STORM AND INTERFERONS AS A POTENTIAL DRUG THERAPY
Author(s) -
R. Ishwarya,
Vipin Kumar,
K.V. Leela
Publication year - 2020
Publication title -
international journal of scientific research
Language(s) - English
Resource type - Journals
ISSN - 3046-5206
DOI - 10.36106/ijsr/3514732
Subject(s) - cytokine storm , ards , immunology , medicine , immune system , cytokine , coronavirus , pathogenesis , pandemic , drug , inflammation , tumor necrosis factor alpha , disease , covid-19 , infectious disease (medical specialty) , lung , pharmacology
Novel Coronavirus (SARS-CoV-2) causing Coronavirus disease (COVID-19) has become a pandemic and has not been previously identified in humans. Transmission among humans occurs through respiratory droplets of infected individual. Patients infected with SARS-CoV-2 undergo acute respiratory distress because of Cytokine storm which serve as the major cause of morbidity and mortality in affected individuals. Cytokines are defined as non-structural proteins which are small with low molecular weight and have a greater regulatory influence in inflammation and immunity. They are considered as the intercellular messenger in the immune system.Therefore, this article provides a glimpse of advancements made in the area of SARS-CoV-2 infection where Cytokines may be a useful biomarker for both diagnostic and prognostic purpose and also as a therapeutic agent in targeting certain cytokines responsible for Acute Respiratory Distress Syndrome (ARDS) in SARS-CoV-2 infected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom